Search

Why you should read this article: • To understand the causes of peripheral neuropathic pain and its effects on patients’ quality of life • To be aware of the non-pharmacological interventions that may be used to manage peripheral neuropathic pain • To consider how you could support patients to self-manage their peripheral neuropathic pain. Peripheral neuropathic pain is a complex condition that can adversely affect people’s quality of life. Alongside pharmacological interventions, nurses can support patients to self-manage their pain using non-pharmacological interventions such as lifestyle changes and exercise. To do this effectively, nurses should be able to recognise the signs and symptoms of peripheral neuropathic pain and be able to educate patients on appropriate self-management approaches. It is important that nurses provide education, advice and information in a way that patients can understand and check this understanding. This article provides an overview of how nurses can support patients to self-manage peripheral neuropathic pain by using various non-pharmacological interventions. [ABSTRACT FROM AUTHOR]

Peripheral neuropathy is temporary or permanent damage to the nerves of the peripheral nervous system, and nurses in diverse settings will care for patients who are experiencing these symptoms. [ABSTRACT FROM AUTHOR]

This article provides an overview of the management of post-herpetic neuralgia (PHN)--a debilitating nerve pain that continues after the herpes zoster (shingles) rash has cleared. PHN mainly affects older people and although there are a number of treatment options available, drug interactions and side effects frequently limit their use. Nurses need to demonstrate an understanding of the difficulties associated with the management of PHN to provide safe and effective pain relief and to improve the patient's quality of life. [ABSTRACT FROM AUTHOR]

The article offers information on diabetic neuropathy. It identifies factors that increase chances of getting diabetic neuropathy. Tables presented show the symptoms of peripheral neuropathy, as well as recommendations for patients with diabetes. It states the three goals of the treatment for diabetic neuropathy and mentions commonly used medications for this illness. Emphasis is given on the need for patients to monitor their glucose level and to adopt a healthy lifestyle.

The article discusses the signs and symptoms, pathophysiology and management of diabetic peripheral neuropathy (DPN). Patients complain of sensory, motor and paradoxical symptoms. Some of factors which could contribute to DPN are hyperglycemia, dyslipidemia and metabolic syndrome. Clinical management of DPN include pain management and glucose control. Drugs that could be used for DPN include anticonvulsants, opioids and antidepressants.

The article presents an answer to a question about medicines management for peripheral neuropathy cases.

Identifies the signs and symptoms of an eye disease called intracranial mass lesions. Association of the disease to headaches; Complications of attributed to the disease; Management of the disease.

The author looks at the role of preventive ocular medicine in the restoration of bilateral visual function in diabetic patients with retinal disease. He references the Diabetes Visual Function Supplement Study (DiVFuSS) by Paul Chous et al., published in the "British Journal of Ophthalmology" in 2015. He says the study found that using an inexpensive nutritional supplement matrix as treatment improves diabetic peripheral neuropathy. He cites the role of optometrists in this matter.

The article presents the author's views on the risks of diabetic peripheral neuropathy in teenagers with diabetes.

The article reports that according to the SEARCH For Diabetes in Youth study group, youth with type 1 diabetes have risks of developing diabetic peripheral neuropathy.

A quiz concerning post-herpetic neuralgia is presented. INSET: HOW TO USE THIS ASSESSMENT.

Reports on the link of little blue pill to anterior optic neuropathy. Features of patients who had nonarteritic anterior ischemic optic neuropathy after taking Viagra; Conditions of all affected individuals; Caution about the use of Viagra.